ArticleBlood advances2018

TNP-470 skews DC differentiation to Th1-stimulatory phenotypes and can serve as a novel adjuvant in a cancer vaccine.

Derek Hoi-Hang Ho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.